Bioage Labs, Inc. · NASDAQ:BIOA
Rubin Paul D sold 8,820 Bioage Labs, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Rubin Paul D (Chief Medical Officer) sold 8,820 Bioage Labs, Inc. shares at US$17.81 for US$157K under a trading plan, leaving 0 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 8,820 shares
- Price
- US$17.81
- Value
- US$157K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Option exercise | 5,437 | US$4.11 | 5,437 | Direct |
| Apr 1, 2026 | Common Stock | Option exercise | 3,383 | US$6.57 | 8,820 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 8,820 | US$17.81 | 0 | Direct |
Source
Related
- Bioage Labs, Inc.
- Rubin Paul D
- Bioage Labs, Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Form 4 · Barton Shane · Jul 1, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · May 15, 2026
- Schedule 13G/A · VK Services, LLC · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026